Provided by Tiger Trade Technology Pte. Ltd.

Lineage Cell Therapeutics Inc

1.02
-0.0150-1.46%
Volume:45.98K
Turnover:46.70K
Market Cap:256.70M
PE:-5.47
High:1.03
Open:1.02
Low:1.01
Close:1.03
52wk High:2.09
52wk Low:1.00
Shares:252.91M
Float Shares:191.00M
Volume Ratio:2.67
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1855
EPS(LYR):-0.2761
ROE:-60.06%
ROA:-17.04%
PB:4.21
PE(LYR):-3.68

Loading ...

Lineage Cell Therapeutics Wins US Patent for AlloSCOPE 5D Cell Manufacturing Platform, Expiry June 2043

Reuters
·
Sep 08

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Lineage Therap (LCTX) and BioLife Solutions (BLFS)

TIPRANKS
·
Aug 07

Lineage Cell Therapeutics Q2 Revenue Falls but Posts Profit

Reuters
·
Aug 07

Lineage Cell Therapeutics Q2 Income from Operations USD -8.923 Million

Reuters
·
Aug 07

Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 07

Lineage Cell Therapeutics to Report Q2 Results, Host Conference Call

Reuters
·
Jul 30

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

THOMSON REUTERS
·
Jul 30

Lineage Therap (LCTX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jul 14

Lineage Cell Therapeutics - to Advance Cor1 into In-vivo Animal Testing with Initial Data Expected This Year

THOMSON REUTERS
·
Jul 13

Lineage Provides Update on Cor1 Cell Therapy Program for Corneal Endothelial Disease

THOMSON REUTERS
·
Jul 13

Lineage Cell Therapeutics shareholders elect seven directors at annual meeting

Reuters
·
Jun 13

H.C. Wainwright Reaffirms Their Buy Rating on Lineage Therap (LCTX)

TIPRANKS
·
May 27

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) and RenovoRx (RNXT)

TIPRANKS
·
May 16

Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives

Simply Wall St.
·
May 15

Canaccord Genuity Reaffirms Their Buy Rating on Lineage Therap (LCTX)

TIPRANKS
·
May 13

Lineage net loss widens to $4.8 million in Q1 FY26; revenue rises to $1.7 million

Reuters
·
May 13

BRIEF-Lineage Cell Therapeutics Q1 Operating Expenses USD 9.318 Million

Reuters
·
May 13

Lineage Cell Therapeutics Q1 EPS USD -0.03

THOMSON REUTERS
·
May 13

Press Release: Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 13

Analysts Are Bullish on Top Healthcare Stocks: Lineage Therap (LCTX), IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06